|
PPP3R1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.983600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.344620E-01 |
| Normal-vs-Stage2 |
5.688300E-02 |
| Normal-vs-Stage3 |
2.875600E-02 |
| Normal-vs-Stage4 |
1.584280E-02 |
| Stage1-vs-Stage2 |
4.432800E-01 |
| Stage1-vs-Stage3 |
2.405600E-01 |
| Stage1-vs-Stage4 |
1.894150E-01 |
| Stage2-vs-Stage3 |
9.190000E-01 |
| Stage2-vs-Stage4 |
7.928400E-01 |
| Stage3-vs-Stage4 |
8.503800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.336400E-02 |
| Normal-vs-AfricanAmerican |
9.081200E-01 |
| Normal-vs-Asian |
2.635800E-02 |
| Caucasian-vs-AfricanAmerican |
1.954770E-01 |
| Caucasian-vs-Asian |
5.797000E-01 |
| AfricanAmerican-vs-Asian |
1.052590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.302300E-02 |
| Normal-vs-Female |
6.153800E-02 |
| Male-vs-Female |
7.707600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.070400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.617630E-02 |
| Normal-vs-Age(61-80Yrs) |
3.267900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.574400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.228000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.772400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.661600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.967600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.113400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.127600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.364600E-01 |
| Classical-VS-Follicular |
3.721600E-01 |
| Classical-VS-Other |
1.817980E-01 |
| Classical-VS-Normal |
1.472390E-01 |
| Tall-VS-Follicular |
6.759000E-01 |
| Tall-VS-Other |
4.869400E-01 |
| Tall-VS-Normal |
3.892400E-02 |
| Follicular-VS-Other |
4.534000E-01 |
| Follicular-VS-Normal |
6.429500E-02 |
| Other-VS-Normal |
5.458100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.062100E-02 |
| Normal-vs-N1 |
9.238800E-04 |
| N0-vs-N1 |
1.546790E-01 |
|
|
